Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2
<p>Abstract</p> <p>Background</p> <p>SYT-SSX is the oncogene associated with synovial sarcoma (SS), a stem cell disease. SYT-SSX is thought to be responsible for sarcoma initiation and development. It interacts with components of Polycomb and SWI/SNF complexes, the two...
Main Authors: | Garcia Christina B, Shaffer Christian M, Eid Josiane E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Genomics |
Online Access: | http://www.biomedcentral.com/1471-2164/13/189 |
Similar Items
-
The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.
by: Roy Barco, et al.
Published: (2009-01-01) -
SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
by: Sakura Tamaki, et al.
Published: (2015-01-01) -
Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas
by: Yanli Cheng, et al.
Published: (2022-05-01) -
Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.
by: Luisa Cironi, et al.
Published: (2009-01-01) -
Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression
by: Miwa Tanaka, et al.
Published: (2020-01-01)